No Data
Earnings Preview: Biote to Report Financial Results Post-market on November 12
$biote(BTMD.US)$ is scheduled to release its financial results post-market on November 12 ET. Earnings PreviewAnalysts estimate $biote(BTMD.US)$ to post revenue of USD51.38M for 2024Q3, up 12.79% YOY;
Wall Street Analysts See an 88.04% Upside in Biote Corp. (BTMD): Can the Stock Really Move This High?
Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call
TD Cowen Maintains Biote(BTMD.US) With Buy Rating, Maintains Target Price $7
TD Cowen analyst Jonna Kim maintains $biote(BTMD.US)$ with a buy rating, and maintains the target price at $7.According to TipRanks data, the analyst has a success rate of 41.2% and a total average
Analysts Are Bullish on These Healthcare Stocks: Biote (BTMD), Ardent Health Partners, Inc. (ARDT)
Earnings Call Summary | Biote(BTMD.US) Q2 2024 Earnings Conference
No Data
No Data